← SynDRA
MW-150
SynDRA canonical compound SYN0039303 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | MAPK14 |
| Mechanism of action | p38 mapk inhibitor |
| Indication | alzheimer's disease |
| Disease area | neurology/psychiatry |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- MW 150
- MW150
- 3GF
- 6-(4-methyl-1-piperazinyl)-3-(2-naphthalenyl)-4-(4-pyridinyl)-pyridazine
- 6-(4-Methyl-piperazin-1-yl)-(2-naphthalen-2-yl)-4-pyridin-4-ylpyridazine
- 6-(4-Methylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)pyridazine
- 6-(4-methylpiperazin-1-yl)-3-naphthalen-2-yl-4-pyridin-4-ylpyridazine
- AKOS040758765
- BDBM50537600
- CHEMBL4129018
- CIIVUDIZZJLXCN-UHFFFAOYSA-N
- compound 11 [PMID: 30978288]
- compound 27 [WO2014145485A2]
- compound 8 [PMID: 25676389]
- CS-0069509
- EPZ68T461K
- EX-A3206A
- GTPL10524
- HY-120111
- MS-26255
- MW01-18-150SRM
- NSC785340
- NSC-785340
- Pyridazine, 6-(4-methyl-1-piperazinyl)-3-(2-naphthalenyl)-4-(4-pyridinyl)-
- Q27453797
- SCHEMBL16061104
- UNII-EPZ68T461K
- RefChem:1090054
- orb1301743
- SCHEMBL29657684
- SCHEMBL30875960
- C24H23N5
- DQC50291
- MFCD32062790
- MW-150?
- AC-38144
- DA-75821
- T5494
Look up MW-150 in the interactive SynDRA portal →